Clearstead Advisors, LLC Aurinia Pharmaceuticals Inc. Transaction History
Clearstead Advisors, LLC
- $6.94 Billion
- Q2 2025
A detailed history of Clearstead Advisors, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 332 shares of AUPH stock, worth $3,768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
332Holding current value
$3,768% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AUPH
# of Institutions
243Shares Held
62.4MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$114 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$105 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$45.1 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$31.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$27.2 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.61B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...